JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Characteristics
Peer reviewed
Abstract
Abstract: Der Dimethoxy‐methyl‐ benzaldehyd (I) reagiert nach Wittig zu den Propenylderivaten (III), die mit Diazoessigester (IV) die Cyclopropancarbonsäureester (V) bilden; letztere sind auch aus dem Ester (IX) zugänglich und liefern mit Hydrazin die Hydrazide (VI).
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
ChemInform Abstract: RESOLUTION AND ABSOLUTE CONFIGURATION OF TRANS‐2‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)CYCLOPROPYLAMINE, A POTENT HALLUCINOGEN ANALOG
Chemischer Informationsdienst
August 21, 1979
ChemInform Abstract: THE SYNTHESIS OF ANALOGS OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE (DOM) PART 2, SOME RING‐METHOXYLATED 1‐AMINO‐ AND 2‐AMINOINDANES
Chemischer Informationsdienst
April 30, 1974
ChemInform Abstract: THE SYNTHESIS OF SOME ANALOGS OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE (DOM) PART 3, SOME DERIVATIVES OF 3‐PHENYLALANINE
Chemischer Informationsdienst
April 30, 1974
ChemInform Abstract: BEHAVIORAL AND SEROTONIN RECEPTOR PROPERTIES OF 4‐SUBSTITUTED DERIVATIVES OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXYPHENYL)‐2‐AMINOPROPANE
Chemischer Informationsdienst
March 8, 1983
ChemInform Abstract: THE SYNTHESIS OF FOUR POSSIBLE IN VITRO METABOLITES OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE (DOM)
Chemischer Informationsdienst
April 30, 1974
For research and education, not medical advice. Talk with a clinician about your own care.
© 2026 The Consciousness Library
Support Our Mission
Choose your preferred way to support The Consciousness Library's work in advancing consciousness research.
A registered 501(c)(3) nonprofit; donations are tax-deductible in the US.
Donations are processed by Mindscape Collective, our legal entity, and may appear that way on your statement.